Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s): CLAZF

Healthcare

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.

TSXV:CLAS.H - Post by User

Claritas Pharmaceuticals Inc > Hey Scotty, since you have and account, check it out.

<< Previous

Bullboard Posts

Next >>

Comment by Scottyon Oct 23, 2020 7:45am

185 Views

Post# 31770270

RE:Hey Scotty, since you have and account, check it out.

What theory? I said KLY is toast no matter what other companies do lol.

Doesn't matter though does it? I'm sure you or Jack, probably Jack from what I saw, will take any post I make and reword it or leave whole sentences out and respond to it over there in your troll section where I couldn't see it like a total dishonest coward.

I get it though, you crazy pumpers need a hugbox with full editorial control to convince anyone of this companies potential at this point. Good luck with that btw, can't wait for this to open so I can legit belly laugh at you cowards.

<< Previous

Bullboard Posts

Next >>

Who, why, and what of the great "Crypto Surge"